30
Participants
Start Date
May 10, 2020
Primary Completion Date
November 17, 2022
Study Completion Date
May 10, 2024
Validation of miRNA-serum signatures associated with IDH1 status
Validation of miRNA-serum signatures associated with IDH1 status and prognosis, as reliable, specific and sensitive circulating diagnostic biomarkers also useful to improve prognostic stratification of patients.
"Regina Elena National Cancer Institute", Rome
Azienda Ospedaliero Universitaria di Sassari
OTHER
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
OTHER
University of Roma La Sapienza
OTHER
Plymouth State University
OTHER
Regina Elena Cancer Institute
OTHER